Role of vascular endothelial growth factor in diabetic nephropathy
- 1 September 2000
- journal article
- Published by Elsevier in Kidney International
- Vol. 58, S104-S112
- https://doi.org/10.1046/j.1523-1755.2000.07717.x
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Molecular mechanisms of glucose action on angiotensinogen gene expression in rat proximal tubular cellsKidney International, 1999
- Understanding the nature of renal disease progressionKidney International, 1997
- The Vascular Endothelial Growth Factor Receptor Flt-1 Mediates Biological ActivitiesJournal of Biological Chemistry, 1996
- The pathogenesis of vascular complications of diabetes mellitus: one voice or many?European Journal of Clinical Investigation, 1996
- Angiotensin II Increases Vascular Permeability Factor Gene Expression by Human Vascular Smooth Muscle CellsHypertension, 1995
- Cellular events in the evolution of experimental diabetic nephropathyKidney International, 1995
- Human mesangial cells and peripheral blood mononuclear cells produce vascular permeability factorKidney International, 1993
- Lovastatin inhibits proliferation of rat mesangial cells.Journal of Clinical Investigation, 1993
- Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesisNature, 1992
- Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis.Journal of Clinical Investigation, 1989